State says it’s preparing for 5 million doses of COVID vaccine. Who gets it and how?

State says it’s preparing for 5 million doses of COVID vaccine. Who gets it and how?
How the federal government manages the messaging about a vaccine is going to be crucial to managing public expectations, public health experts said.

Peter Pitts, president of the Center for Medicine in the Public Interest and a former FDA associate commissioner for external relations, said one of the biggest challenges states will face when distributing a new vaccine is public skepticism.

“Having a vaccine that nobody uses is a public health failure,” he said, adding that time is running out for public health officials to get out a persuasive message.

Americans already are skeptical. A poll released Monday by Harris and STAT found that 78% of Americans believe that the COVID-19 vaccine process is being driven more by politics than science.

But when it comes to trust in the president, the public breaks down along partisan lines. Although only 46% of the public trust the president or the White House to provide accurate information about the development of a COVID-19 vaccine, 71% of Republicans believe Trump compared to only 28% of Democrats.

There is more trust in the FDA than the president: 68% say they are confident that the FDA will only endorse a vaccine that is safe.

Gruters, who is one of the president’s most vocal cheerleaders in Florida, said he expects most of the public will trust a vaccine.

“There is a lot of distrust in government overall, but the FDA and its policies and science transcends politics,’’ he said. “If they say it’s ready and if they are getting results in these trials, then I’m confident.”

In a presidential election year, Pitts said, the pandemic and the government’s response have become “hyper-politicized.”

“If you don’t believe the messenger, you’re not going to believe the message.”



 
Sign Up for Our Email Newsletter

RECENT NEWS

Richard Bagger Joins CMPI Board of Directors
  • CMPI
  • 09/05/2023 12:00 AM

Richard Bagger Joins CMPI Board of Directors

Richard Bagger, a well-known and respected expert in healthcare and biopharmaceutical policy, has joined the Center for M...  Read more

Reality-Based Healthcare Reform

Reality-Based Healthcare Reform

When it comes to innovation in the development of new medicines, a key focus is on “Real World Evidence,” or data based o...  Read more

Inflation Reduction Act’s Medicare drug price negotiation program is unconstitutional

Inflation Reduction Act’s Medicare drug price negotiation program is unconstitutional

Protecting American health care with true grit...  Read more

DRUGWONKS BLOG